Gauging Gait Disorders with a Method Inspired by Motor Control Theories: A Pilot Study in Friedreich’s Ataxia

Abstract

To date, it has been challenging for clinicians and researchers alike to use the multiple outcome measures available to create a meaningful clinical picture and perform effective longitudinal follow-up. It has been found that instrumented gait analysis can provide information associated with a patient’s performance and help to remedy the shortcomings of the currently available outcome measures. The goal of this methodological article is to set the background and justify a new outcome measure inspired by the motor control theories to analyze gait using spatiotemporal parameters. The method is applied in a population of individuals living with Friedreich’s ataxia (FRDA), a neurodegenerative disease. The sample population consisted of 19 subjects, 11 to 65 years of age with FRDA, who either ambulated independently, with a cane, or with a rollator. Three scores based on the distance from healthy normative data were used: Organization Score, Variability Score, and an overall measurement, the Global Ambulation Score. The scores were then compared to the Scale for Assessment and Rating of Ataxia (SARA) Gait Score (SARA-GS), a clinical scale currently being used for gait analysis in FRDA. Organization Scores demonstrated a longitudinal deterioration in the gait characteristics from independent ambulators to those who ambulated with a rollator. Variability Scores mostly reflected dynamic instability, which became greater as the requirement of an ambulation aid or the switch from a cane to a rollator was imminent. The global value given by the Global Ambulation Score, which takes into consideration both the Organization Score, the Variability Score, and the level of assistive device, demonstrated a logarithmic relationship with the SARA-GS. Overall, these results highlight that both components introduced should be analyzed concurrently and suggest that the Global Ambulation Score may be a valuable outcome measure for longitudinal disease progression.

Athlete Gait Feature Recognition Method Based on Multisource Sensing Information

“…In order to make the athlete gait feature contour segmentation network more accurate in the output results and more stable in multiscale athlete gait feature contour segmentation, it is necessary to carry out relevant design in the backbone network for feature extraction. At the same time, in order to complete the instance segmentation task of human contour [9], the human body detection frame and athlete's gait feature contour segmentation networks must both be produced at the same time by the athlete's gait feature contour segmentation network. As a result, we must consider both the function of human body detection and the athlete's gait feature contour segmentation while developing and creating the network.…”

Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trial

“…The eGVI differentiates low and high gait variability. For the eGVI, a score closest to 100 is better [12] . The FAP is reflective of the organization of the gait pattern and the eGVI of gait variability [12] .…”

Ataxia severity classification using enhanced feature selection and ranking optimization through machine learning model

“…Approximately 70% of neurological hospitalized patients have abnormal gait activity, Alsaif et al [2], suggesting that the gait based evaluation method [3] can be used to make an earlier identification of neurological disease [4]. The primary goal of this study is to use gait analysis to diagnose ataxic neurologicaldisorder [5]. Developing a gait based method capable of automated identification and monitoring of neurological conditions improves the effectiveness of the treatment, facilitates treatment strategies, and helps to ease the burden on the healthcare-management system [6].…”